Quantcast
Home > Quotes > ALXN
ALXN

Alexion Pharmaceuticals, Inc. Common Stock (ALXN) Quote & Summary Data

$113.91
*  
1.69
1.46%
Get ALXN Alerts
*Delayed - data as of Dec. 10, 2018 10:12 ET  -  Find a broker to begin trading ALXN now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
View:    ALXN Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
$ 113.86 / $ 114.05
1 Year Target
165
Today's High / Low
$ 115.993 / $ 113.24
Share Volume
231,368
50 Day Avg. Daily Volume
1,599,058
Previous Close
$ 115.60
52 Week High / Low
$ 140.77 / $ 102.10
Market Cap
25,412,937,351
P/E Ratio
172.59
Forward P/E (1y)
16.95
Earnings Per Share (EPS)
$ 0.66
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
1.59

Intraday Chart

Shares Traded

Share Volume:
231,368
50 Day Avg. Daily Volume:
1,599,058

P/E Ratio

P/E Ratio:
172.59
Forward P/E (1y):
16.95
Earnings Per Share (EPS):
$ 0.66

Trading Range

The current last sale of $113.91 is 11.57% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 115.993 $ 140.77
 Low: $ 113.24 $ 102.10

ETFs with ALXN as a Top 10 Holding*

Weighting ETF Name (Symbol) 100-Day Price Change (%)
4.94% VanEck Vectors Biotech ETF (BBH) -10.16 (-7.90%)
3.7% iShares Nasdaq Biotechnology Index Fund (IBB) -14.73 (-12.44%)
1.53% SPDR Series Trust SPDR S&P Biotech ETF (XBI) -22.16 (-22.08%)
*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change.
**Green highlights the top performing ETF by % change in the past 100 days.

Company Description (as filed with the SEC)

Alexion Pharmaceuticals, Inc. (Alexion, the Company, we, our or us) is a global biopharmaceutical company focused on serving patients and families affected by rare diseases through the innovation, development and commercialization of life-changing therapies. We are the global leader in complement inhibition and have developed and commercialize the first and only approved complement inhibitor to treat patients with paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), and anti-acetylcholine receptor (AChR) antibody-positive generalized myasthenia gravis (gMG). In addition, Alexion has two highly innovative enzyme replacement therapies for patients with life-threatening and ultra-rare metabolic disorders, hypophosphatasia (HPP) and lysosomal acid lipase deficiency (LAL-D).  ... More ...  


Risk Grade

Where does ALXN fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 115.65
Open Date:
Dec. 10, 2018
Close Price:
N/A
Close Date:
N/A

Consensus Recommendation

Analyst Info